2.95
Acrivon Therapeutics Inc-Aktien (ACRV) Preisverlauf
Täglich
Wöchentlich
Monatlich
7T
30T
60T
YTD
1J
| Datum | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2026-01-07 | $3.56 | $2.86 | $0.70 | 2,938,373.0 | -1.99% |
| 2026-01-06 | $3.15 | $2.32 | $0.83 | 3,190,161.0 | +31.44% |
| 2026-01-05 | $2.50 | $2.27 | $0.2265 | 544,593.0 | -6.91% |
| 2026-01-02 | $2.49 | $2.37 | $0.12 | 311,700.0 | +2.07% |
| 2025-12-31 | $2.48 | $2.38 | $0.10 | 222,246.0 | -1.23% |
| 2025-12-30 | $2.49 | $2.36 | $0.13 | 287,996.0 | +3.39% |
| 2025-12-29 | $2.59 | $2.34 | $0.25 | 564,664.0 | -3.28% |
| 2025-12-26 | $2.50 | $2.32 | $0.18 | 180,020.0 | +2.09% |
| 2025-12-24 | $2.40 | $2.31 | $0.095 | 88,619.0 | +3.02% |
| 2025-12-23 | $2.37 | $2.26 | $0.11 | 221,202.0 | +0.00% |
| 2025-12-22 | $2.44 | $2.16 | $0.28 | 339,287.0 | +7.41% |
| 2025-12-19 | $2.28 | $2.12 | $0.16 | 765,398.0 | -4.42% |
| 2025-12-18 | $2.39 | $2.18 | $0.21 | 643,756.0 | -2.16% |
| 2025-12-17 | $2.58 | $2.26 | $0.32 | 687,040.0 | -4.55% |
| 2025-12-16 | $2.62 | $2.37 | $0.25 | 362,249.0 | -5.84% |
| 2025-12-15 | $2.60 | $2.42 | $0.1806 | 513,423.0 | +1.58% |
| 2025-12-12 | $2.72 | $2.51 | $0.2065 | 361,093.0 | -3.07% |
| 2025-12-11 | $2.73 | $2.58 | $0.15 | 357,148.0 | -0.38% |
| 2025-12-10 | $2.66 | $2.44 | $0.22 | 372,482.0 | +5.22% |
| 2025-12-09 | $2.60 | $2.46 | $0.1439 | 698,518.0 | -1.19% |
Acrivon Therapeutics Inc-Aktien (ACRV) Preisverlauf Jahr für Jahr
In dieser detaillierten Analyse präsentieren wir einen umfassenden Überblick über die Kursbewegungen der Acrivon Therapeutics Inc-Aktie im Laufe der Jahre. Durch die Untersuchung der Jahresdaten können Investoren wertvolle Einblicke in die historische Performance und Volatilität der ACRV-Aktien gewinnen. Von bedeutenden Meilensteinen und Schwankungen bis hin zu bemerkenswerten Trends bietet diese gründliche Untersuchung der Preisgeschichte der Acrivon Therapeutics Inc-Aktie eine Grundlage für das Verständnis der Entwicklung der Aktien des Unternehmens im Laufe der Zeit.
Acrivon Therapeutics Inc-Aktien (ACRV) Preisverlauf 2026
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2026-01 | $3.56 | $2.27 | $1.29 | 9,923,200.0 | +22.41% |
Acrivon Therapeutics Inc-Aktien (ACRV) Preisverlauf 2025
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2025-12 | $2.73 | $2.12 | $0.61 | 9,529,631.0 | +3.39% |
| 2025-11 | $2.48 | $1.78 | $0.7009 | 25,175,686.0 | +18.59% |
| 2025-10 | $2.17 | $1.69 | $0.49 | 9,191,176.0 | +9.94% |
| 2025-09 | $2.67 | $1.30 | $1.37 | 65,831,207.0 | +35.07% |
| 2025-08 | $1.44 | $1.20 | $0.2348 | 3,796,173.0 | +4.69% |
| 2025-07 | $1.50 | $1.15 | $0.345 | 6,316,057.0 | +7.56% |
| 2025-06 | $1.41 | $1.05 | $0.36 | 10,293,267.0 | +13.33% |
| 2025-05 | $1.50 | $1.05 | $0.45 | 15,442,913.0 | -25.00% |
| 2025-04 | $2.19 | $1.30 | $0.89 | 24,369,680.0 | -31.03% |
| 2025-03 | $5.75 | $2.02 | $3.73 | 3,486,033.0 | -61.77% |
| 2025-02 | $8.00 | $4.69 | $3.31 | 1,549,969.0 | -12.52% |
| 2025-01 | $7.18 | $5.28 | $1.90 | 708,649.0 | +0.83% |
Acrivon Therapeutics Inc-Aktien (ACRV) Preisverlauf 2024
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2024-12 | $7.82 | $5.40 | $2.42 | 1,258,567.0 | -28.63% |
| 2024-11 | $8.74 | $6.11 | $2.63 | 946,506.0 | -5.25% |
| 2024-10 | $8.46 | $6.85 | $1.61 | 1,561,460.0 | +14.29% |
| 2024-09 | $10.00 | $6.95 | $3.05 | 2,669,110.0 | -26.24% |
| 2024-08 | $10.16 | $6.87 | $3.29 | 1,336,977.0 | +13.25% |
| 2024-07 | $9.24 | $5.74 | $3.50 | 1,981,107.0 | +44.48% |
| 2024-06 | $8.15 | $5.50 | $2.65 | 2,381,138.0 | -24.87% |
| 2024-05 | $10.29 | $7.46 | $2.83 | 2,619,712.0 | -15.07% |
| 2024-04 | $11.90 | $5.70 | $6.20 | 44,580,956.0 | +27.13% |
| 2024-03 | $7.31 | $4.49 | $2.82 | 1,836,717.0 | +47.12% |
| 2024-02 | $5.46 | $3.19 | $2.27 | 1,710,559.0 | +33.15% |
| 2024-01 | $5.31 | $3.46 | $1.85 | 1,137,420.0 | -25.81% |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):